efficacy of tirzepatide Study: produces greater weight loss vs. other GLP-1s Efficacy and Safety of Tirzepatide

The clinical literature supports this approach, as delayed escalation does not appear to compromise long-term weight loss outcomes

Clinical Topics: Cardiac Surgery, Heart Failure and Cardiomyopathies, Invasive Cardiovascular Angiography and Intervention, Cardiac Surgery and Heart Failure, Acute Heart Failure Keywords: American Heart Association, AHA Annual Scientific Sessions, AHA24, Diabetes Mellitus, Type 2, Heart Failure, Glucagon-Like Peptide 1, Obesity, Coronary Artery Bypass

Weight Loss Via Lifestyle Intervention Can Change Cardiac Biomarkers A secondary analysis of the LookAHEAD trial showed that lifestyle interventions targeting weight loss for type 2 diabetes patients led to a change in biomarkers associated with higher risk of cardiovascular disease and heart failure (HF)

GLP-1s work predominantly in the brain, says Cooper at UC Irvine

Because spironolactone can sometimes cause fatigue, ensuring you are getting adequate vitamins and minerals is vital